3 years 0
Extreme 0.0008
0.01
5 years 0
Extreme 0.0008
0.04
Manager TitleAgeSince
Chief Executive Officer 84 01/06/2020
Chief Operating Officer 72 01/06/2020
Chief Tech/Sci/R&D Officer 72 04/05/2021
Director TitleAgeSince
Chairman 84 01/06/2020
Director/Board Member 72 01/06/2020
Director/Board Member 56 -
Change 5-day change 1-year change 3-year change Capi.($)
-11.11%+14.29%-69.23%-91.58% 0
+0.19%-2.21%+3.94%+187.45% 324B
-0.55%-2.17%+10.35%+158.63% 250B
-2.63%-4.52%-6.77%+47.82% 171B
+0.70%-0.82%+25.05%+579.50% 161B
-2.21%-2.18%+9.58%+123.54% 157B
+0.54%-4.52%-12.68%+0.04% 147B
-0.94%-3.70%+1.07%+23.66% 118B
+1.08%-0.55%+17.07%+402.23% 90.2B
+0.35%-1.04%-2.34%+49.28% 89.64B
Average -1.47%-2.14%-2.40%+148.06% 150.84B
Weighted average by Cap. -0.46%-2.36%+5.20%+175.60%
Logo HALBERD
Halberd Corporation is a technology holding company. The Company is focused on developing solutions for healthcare and medical applications. Its portfolio includes approaches to disease treatment, diagnostic technologies, and artificial intelligence (AI)-powered healthcare platforms. It has acquired licenses to two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and cerebrospinal fluid-related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other viruses. Its subsidiary, NeuroSense AI Corp., is a behavioral intelligence platform in development combining AI with multi-modal sensor technology that integrates ultrasonic vocalization analysis, micro-movement tracking, and social behavior monitoring through Claude AI-powered interpretation to provide unprecedented insights into brain health and recovery patterns. Its subsidiaries also include Alaric Corporation and Extendalife, Inc.
Employees
-
Date Price Change Volume
25/09/26 US$0.000000 - 806,298
  1. Stock Market
  2. Stocks
  3. HALB Stock